Insulin vs Oral Agents: When to Use Which in Diabetes Management

Does the patient have Type 1 DM?

• YES → Insulin ALWAYS. No exceptions.

  • No endogenous insulin production; oral agents cannot work
  • Basal-bolus regimen: long-acting (glargine/detemir) once or twice daily + rapid-acting (lispro/aspart) before meals
  • Oral agents are never appropriate — even if the patient "feels fine"

• NO → Type 2 DM. Ask the next question.

Is the patient in DKA or HHS?

• YES → Insulin drip (regular insulin IV). Oral agents are contraindicated in acute crisis.

  • DKA: typically Type 1 but can occur in Type 2
  • HHS: Type 2 with severe hyperglycemia (glucose often > 600 mg/dL)
  • Monitor glucose hourly; transition to subcutaneous insulin when eating and anion gap closes
  • May transition to oral agents later once stabilized (Type 2 only)

• NO → Continue below.

Is the patient pregnant (GDM or pre-existing DM)?

• YES → Insulin is the preferred agent.

  • Metformin crosses the placenta; insulin does NOT — safest for the fetus
  • Metformin may be used in GDM if insulin is refused or inaccessible, but insulin remains first-line
  • Rapid-acting (lispro) for mealtime + intermediate or long-acting for basal coverage
  • Monitor blood glucose before meals and 1-2 hr postprandially

• NO → Continue below.

Is the patient hospitalized or NPO?

• YES → Hold metformin. Use insulin.

  • Metformin + IV contrast = lactic acidosis risk; hold 48 hr around contrast studies
  • NPO patients need basal insulin ± correction-dose (sliding scale) regular or rapid-acting insulin
  • Resume oral agents when eating consistently and renal function confirmed

• NO → Outpatient Type 2 DM. Check the A1C.

A1C < 9% at new diagnosis?

• YES → Lifestyle modifications + metformin first-line
  • Start metformin 500 mg daily, titrate to 1000 mg BID
  • Teach: take with food (reduces GI side effects), hold before contrast
  • Check renal function (contraindicated if eGFR < 30)
  • Does NOT cause hypoglycemia when used alone
  • Reassess A1C in 3 months

A1C 9–10% or symptomatic hyperglycemia (polyuria, polydipsia, weight loss)?

• Dual therapy: metformin + second oral agent OR metformin + basal insulin (glargine)
  • Adding basal insulin at bedtime is common when symptoms are prominent
  • Second oral agents include sulfonylureas (glipizide), SGLT2 inhibitors, DPP-4 inhibitors
  • Sulfonylureas DO cause hypoglycemia — teach the patient to recognize it

A1C > 10% at diagnosis?

• Start insulin (basal ± bolus) even in Type 2 — glucose toxicity impairs oral agent effectiveness
  • May add metformin concurrently once glucose stabilizes
  • Can potentially transition off insulin to oral agents if A1C improves and beta-cell function recovers